|
Market Closed -
Nasdaq
01:30:00 29/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 76.61 USD | +6.18% |
|
+13.06% | +29.74% |
| 26/10 | Tempus AI Receives EU Certification for xR RNA Sequencing | MT |
| 24/10 | Tempus AI, Inc. Enters Into Multi-Year Agreement With Bristol Myers Squibb To License Multimodal Oncology Data | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.38TCr | - | ||||
| 6.41TCr | |||||
| 5.55TCr | |||||
| 5.3TCr | |||||
| 4.6TCr | |||||
| 4.25TCr |
- Stock Market
- Stocks
- TEM Stock
- Charts Tempus AI, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
